Biotech experts wary of Pfizer cutting Seagen workforce — but history reveals silver lining Seattle-area biotech experts are eying the past warily in the wake of this week’s news that Pfizer plans to acquire… Read More
Seagen vets land $4.4M for Univ. of Washington spinout using fresh approach for cancer vaccines A biotech startup spun out of the University of Washington and led by veterans of Seattle-area biotech giant Seagen has… Read More
